Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.
Journal Information
Full Title: Ann Rheum Dis
Abbreviation: Ann Rheum Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests: CPD has received research grants to the institution from Servier, Horizon, Arxx Therapeutics and GlaxoSmithKline, consulting fees from Arxx Therapeutics, Roche, Janssen, GlaxoSmithKline, Bayer, Sanofi, Galapagos, Boehringer Ingelheim, CSL Behring, and Acceleron, and honoraria from Janssen, Boehringer Ingelheim, and Corbus. CDB has stocks in Mestag Therapeutics. Other authors declare that they have no competing interests."
"Funding: This work was funded by a research grant to UCL from GlaxoSmithKline, and Medical Research Council UK grant MR/T001631/1 (fellowship to KENC)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025